Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting complement in severe coronavirus disease 2019 to address microthrombosis

28 May 2020

Abstract excerpt

There is no approved therapy for coronavirus disease 2019 (COVID-19) [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection], and the number of worldwide deaths on current standard therapy is staggering [1]. Current therapy is aimed at decreasing viral replication, supporting vital functions and addressing the most damaging consequences of the disease such as hyperinflammation (the so-called...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32695331
DOI: 10.1093/ckj/sfaa095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Targeting complement in severe coronavirus disease 2019 to address microthrombosisPMID 32695331Read ↗

Complement and coagulation: key triggers of COVID-19–induced multiorgan pathologySemantic proximity Read ↗

The complement system in COVID-19: friend and foe?Semantic proximity Read ↗

Complement cascade in severe forms of COVID‐19: Recent advances in therapySemantic proximity Read ↗

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.Semantic proximity Read ↗

From COVID-19 to clot: the involvement of the complement systemSemantic proximity Read ↗

Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19.Semantic proximity Read ↗

The Fundamental Role of Prophylactic Anticoagulation Therapy and the Complications of Hypercoagulability in Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Semantic proximity Read ↗

Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations.Semantic proximity Read ↗

Generation of Inhibitory Autoantibodies to ADAMTS13 in Coronavirus Disease 2019Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.